New concepts in the management of diffuse low-grade glioma: Proposal of a multistage and individualized therapeutic approach

Neuro-Oncology

Volumn 17, Issue 3, 2015, Pages 332-342

  Duffau, Hugues ^a,b   Taillandier, Luc ^c  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Awake surgery; Diffuse low grade gliomas; Individualized management; Multistage therapeutic approach; Quality of life

Indexed keywords

ARTICLE; BRAIN BIOPSY; BRAIN MAPPING; BRAIN SURGERY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; DISEASE COURSE; GLIOMA; HUMAN; MALIGNANT TRANSFORMATION; MANAGED CARE; NERVE CELL PLASTICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PERSONALIZED MEDICINE; QUALITY OF LIFE; REOPERATION; SURGICAL APPROACH; TUMOR GROWTH; TUMOR INVASION; BRAIN NEOPLASMS; MORTALITY; NEUROSURGERY; PATHOPHYSIOLOGY; PSYCHOLOGY; TREATMENT OUTCOME;

BRAIN NEOPLASMS; DISEASE PROGRESSION; GLIOMA; HUMANS; NEUROSURGICAL PROCEDURES; PRECISION MEDICINE; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84987608285     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nou153     Document Type: Article

References (57)

1. Louis D, Ohgaki H, Wiestler O, et al. eds. World Health Organization Classification of Tumors of the Central Nervous System. 4th ed. Lyon: IARC; 2007.
2. Duffau H. Diffuse Low Grade Glioma in Adults: Natural History, Interaction with the Brain, and New Individualized Therapeutic Strategies. Duffau H, ed. London: Springer; 2013.
3. Rigau V. Histological Classification. In Diffuse Low Grade Glioma in Adults: Natural History, Interaction with the Brain, and New Individualized Therapeutic Strategies Duffau H, ed. London: Springer; 2013.
4. Kim YH, Nobusawa S, Mittelbronn M, et al. Molecular classification of low-grade diffuse gliomas. Am J Pathol. 2010;177(6): 2708-2714.
5. Pallud J, Blonski M, Mandonnet E, et al. Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas. Neuro Oncol. 2013;15(5):595-606.
6. van den Bent M, Wefel J, Schiff D, et al. Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol. 2011;12(6):583-593.
7. Duffau H. The huge plastic potential of adult brain and the role of connectomics: New insights provided by serial mappings in glioma surgery. Cortex. 2013; pii: S0010-9452(13)00207-4. doi:10.1016/ j.cortex.2013.08.005. [Epub ahead of print].
8. Duffau H. The challenge to remove diffuse low grade gliomas while preserving brain functions. Acta Neurochir (Wien). 2012; 154(4):569-574.
9. Karim AB, Maat B, Hatlevoll R, et al. A randomized trial on dose-response in radiation therapy on low-grade cerebral glioma. European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Inj J Radiat Oncol Biol Phys. 1996; 36(3):549-556.
10. Karim AB, Afra D, Cornu P, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Inj J Radiat Oncol Biol Phys. 2002;52(2): 316-324.
11. Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol. 2002;20(8):2076-2084.
12. van den Bent MJ, Afra D, de Witte O, et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet. 2005;366(9490):985-990.
13. Jakola AS, Myrmel KS, Kloster R, et al. Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas. JAMA. 2012;308(18):1881-1888.
14. Daniels TB, Brown PD, Felten SJ, et al. Validation of EORTC prognostic factors for adults with low-grade glioma: A report using intergroup 86-72-51. Int J Radiat Oncol Biol Phys. 2011; 81(1):218-224.
15. Berger MS, Deliganis AV, Dobbins J, et al. The effect of extent of resection on recurrence in patients with low-grade cerebral hemisphere gliomas. Cancer. 1994;74(6):1784-1791.
16. Guillevin R, Menuel C, Duffau H, et al. Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas. J Neurooncol. 2008;87(2):181-187.
17. Pallud J, Audureau E, Blonski M, et al. Epileptic seizures in diffuse low-grade gliomas in adults. Brain. 2014;137(Pt 2):449-462.
18. Duffau H, Capelle L. Preferential brain locations of low grade gliomas. Cancer. 2004;100(12):2622-2626.
19. Duffau H. Lessons from brain mapping in surgery for low-grade glioma: insights into associations between tumour and brain plasticity. Lancet Neurol. 2005;4(8):476-486.
20. Klein M, Duffau H, De Witt Hamer PC. Cognition and resective surgery for diffuse infiltrative glioma: an overview. J Neurooncol. 2012;108(2):309-318.
21. Duffau H. Cognitive assessment in glioma patients. J Neurosurg. 2013;119(5):1348-1349.
22. Duffau H. Surgery of low-grade gliomas: towards a "functional neurooncology". Curr Opin Oncol. 2009;21(6):543-549.
23. Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008;62(4):753-766.
24. Smith JS, Chang EF, Lamborn KR, et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol. 2008;26(8):1338-1345.
25. Claus EB, Horlacher A, Hsu L, et al. Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer. 2005;103(6):1227-1233.
26. Duffau H, Lopes M, Arthuis F, et al. Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985-96) and with (1996-2003) functional mapping in the same institution. J Neurol Neurosurg Psychiatry. 2005;76(6):845-851.
27. Yeh SA, Ho JT, Lui CC, et al. Treatment outcomes and prognostic factors in patients with supratentorial low-grade gliomas. Br J Radiol. 2005;78(927):230-235.
28. McGirt MJ, Chaichana KL, Attenello FJ, et al. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery. 2008;63(4):700-707.
29. Chaichana KL, McGirt MJ, Laterra J, et al. Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas. J Neurosurg. 2010;112(1):10-17.
30. Ahmadi R, Dictus C, Hartmann C, et al. Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients. Acta Neurochir (Wien). 2009;151(11): 1359-1365.
31. Schomas DA, Laack NN, Rao RD, et al. Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic. Neuro Oncol. 2009;11(4):437-445.
32. Youland RS, Schomas DA, Brown PD, et al. Changes in presentation, treatment, and outcomes of adult low-grade gliomas over the past fifty years. Neuro Oncol. 2013;15(8): 1102-1110.
33. Ius T, Isola M, Budai R, et al. Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients. J Neurosurg. 2012;117(6):1039-1052.
34. Capelle L, Fontaine D, Mandonnet E, et al. Spontaneous and therapeutic prognostic factors in adult hemispheric WHO grade II gliomas: a series of 1097 cases. J Neurosurg. 2013;118(6): 1157-1168.
35. Soffietti R, Baumert B, Bello L, et al. Guidelines on management of low-grade gliomas: report of an EFNS-EANO task force. Eur J Neurol. 2010;17(9):1124-1133.
36. Yordanova Y, Moritz-Gasser S, Duffau H. Awake surgery for WHO grade II gliomas within "noneloquent" areas in the left dominant hemisphere: toward a "supratotal" resection. J Neurosurg. 2011;115(2):232-239.
37. Muragaki Y, Chernov M, Maruyama T, et al. Low-grade glioma on stereotactic biopsy: how often is the diagnosis accurate? Minim Invasive Neurosurg. 2008;51(5):275-279.
38. Duffau H, Gatignol P, Mandonnet E, et al. Contribution of intraoperative subcortical stimulation mapping of language pathways: a consecutive series of 115 patients operated on for a WHO grade II glioma in the left dominant hemisphere. J Neurosurg. 2008;109(3):461-471.
39. Sanai N, Mirzadeh Z, Berger MS. Functional outcome after language mapping for glioma resection. N Engl J Med. 2008; 358(1):18-27.
40. Sanai N, Chang S, Berger MS. Low-grade gliomas in adults. J Neurosurg. 2011;115(5):948-965.
41. Duffau H. Brain Mapping: From Neural Basis of Cognition to Surgical Applications. Duffau H. ed., New York: Springer Wien; 2011.
42. De Witt Hamer PC, Gil Robles S, Zwinderman A, et al. Impact of intraoperative stimulation brain mapping on glioma surgery outcome: a meta-analysis. J Clin Oncol. 2012;30(20): 2559-2565.
43. Chang EF, Clark A, Smith JS, et al. Functional mapping-guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long term survival. Clinical article. J Neurosurg. 2011;114(3):566-573.
44. Duffau H. Awake surgery for incidental WHO grade II gliomas involving eloquent areas. Acta Neurochir (Wien). 2012;154(4): 575-584.
45. Quinn JA, Reardon DA, Friedman AH, et al. Phase II trial of temozolomide in patients with progressive low-grade glioma. J Clin Oncol. 2003;21(4):646-651.
46. Hoang-Xuan K, Capelle L, Kujas M, et al. Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol. 2004;22(15):3133-3138.
47. Ricard D, Kaloshi G, Amiel-Benouaich A, et al. Dynamic history of low-grade gliomas before and after temozolomide treatment. Ann Neurol. 2007;61(5):484-490.
48. Kaloshi G, Benouaich-Amiel A, Diakite F, et al. Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology. 2007;68(21):1831-1836.
49. Shaw E, Arusell R, Scheithauer B, et al. Prospective randomized trial of low-versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a NCCTG/RTOG/ ECOG study. J Clin Oncol. 2002;20(9):2267-2276.
50. Douw L, Klein M, Fagel SS, et al. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol. 2009;8(9):810-818.
51. Shaw EG, Wang M, Coons SW, et al. Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802. J Clin Oncol. 2012;30(25):3065-3070.
52. Schmidt MH, Berger MS, Lamborn KR, et al. Repeated operations for infiltrative low-grade gliomas without intervening therapy. J Neurosurg. 2003;98(6):1165-1169.
53. Martino J, Taillandier L, Moritz-Gasser S, et al. Re-operation is a safe and effective therapeutic strategy in recurrentWHO grade II gliomas within eloquent areas. Acta Neurochir (Wien). 2009;151(5):427-436.
54. Blonski M, Taillandier L, Herbet G, et al. Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: a study of cognitive status and quality of life. J Neurooncol. 2012;106(2):353-366.
55. Blonski M, Pallud J, Gozé C, et al. Neoadjuvant chemotherapy may optimize the extent of resection of WHO grade II gliomas: a case series of 17 patients. J Neurooncol. 2013;113(2):267-275.
56. Mandonnet E, De Witt Hamer PC, Pallud J, et al. Silent diffuse low-grade glioma: towards screening and preventive treatment? Cancer. 2014. doi:10.1002/cncr.28610.
57. Cancer. 2014;120(12):1758-1762.